| Literature DB >> 29710860 |
Vincenzo Malafarina1,2, Jean-Yves Reginster3,4,5, Sonia Cabrerizo6, Olivier Bruyère7,8, John A Kanis9,10, J Alfredo Martinez11,12,13,14,15, M Angeles Zulet16,17,18,19.
Abstract
Malnutrition is very prevalent in geriatric patients with hip fracture. Nevertheless, its importance is not fully recognized. The objective of this paper is to review the impact of malnutrition and of nutritional treatment upon outcomes and mortality in older people with hip fracture. We searched the PubMed database for studies evaluating nutritional aspects in people aged 70 years and over with hip fracture. The total number of studies included in the review was 44, which analyzed 26,281 subjects (73.5% women, 83.6 ± 7.2 years old). Older people with hip fracture presented an inadequate nutrient intake for their requirements, which caused deterioration in their already compromised nutritional status. The prevalence of malnutrition was approximately 18.7% using the Mini-Nutritional Assessment (MNA) (large or short form) as a diagnostic tool, but the prevalence was greater (45.7%) if different criteria were used (such as Body Mass Index (BMI), weight loss, or albumin concentration). Low scores in anthropometric indices were associated with a higher prevalence of complications during hospitalization and with a worse functional recovery. Despite improvements in the treatment of geriatric patients with hip fracture, mortality was still unacceptably high (30% within 1 year and up to 40% within 3 years). Malnutrition was associated with an increase in mortality. Nutritional intervention was cost effective and was associated with an improvement in nutritional status and a greater functional recovery. To conclude, in older people, the prevention of malnutrition and an early nutritional intervention can improve recovery following a hip fracture.Entities:
Keywords: body mass index; hip fracture; malnutrition; nutritional biomarkers; older adults
Mesh:
Year: 2018 PMID: 29710860 PMCID: PMC5986435 DOI: 10.3390/nu10050555
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Prevalence of malnutrition or risk of malnutrition and nutritional screening tool used in the included studies.
| [ | 17,651 | 9549 | - | 8102 | Albumin < 3.5 g/dL |
| [ | 173 | 49 | - | 57 | BMI < 22 kg/m2 |
| [ | 23 | 9 | 7 | 7 | BMI † |
| [ | 96 | 59 | - | 37 | BMI < 18.5 kg/m2 |
| [ | 60 | 34 | - | 26 | Weight loss ≥ 5% 1 m, or ≥ 10% 6 m, and/or albumin < 2.7 g/dL |
| [ | 25 | 11 | 11 | 3 | Hospital’s own screening tool § |
| Total of subjects | 18,028 | 9711 | 18 | 8232 | |
| Percentage | 53.9% | 45.7% | |||
| [ | 49 | 18 | 23 | 8 | MNA ‡ |
| [ | 80 | 38 | 35 | 7 | MNA |
| [ | 127 | 89 | 36 | 2 | MNA |
| [ | 50 | 32 | 18 | 0 | MNA |
| [ | 50 | 7 | 29 | 14 | MNA |
| [ | 97 | 44 | 37 | 16 | MNA |
| [ | 162 | 59 | - | 103 | MNA |
| [ | 152 | 87 | - | 65 | MNA |
| [ | 215 | 95 | 95 | 25 | MNA-SF ¥ |
| [ | 204 | 55 | 98 | 51 | MNA-SF |
| [ | 594 | 316 | 236 | 42 | MNA-SF |
| [ | 415 | 152 | 185 | 78 | MNA-SF |
| Total of subjects | 2195 | 992 | 774 | 411 | |
| Percentage | 45.2% | 35.3% | 18.7% |
§ This screening tool is based on changes in dietary intake, weight, and other risk factors (pressure ulcers, presence of infection, period of fasting, and the need for help with eating and drinking); † Risk of malnutrition cut-off point: Body Mass Index (BMI) between 20 and 22 kg/m2; ‡ Mini-Nutritional Assessment (MNA) cut-off points: well-nourished ≥ 24 points, at risk for malnutrition at 17–23.5 points, and malnourished at less than 17 points; ¥ Mini-Nutritional Assessment-Short Form (MNA-SF) cut-off points: well-nourished 12–14 points, at risk of malnutrition 8–11 points, and malnourished 0–7 points; WN: well-nourished; RMN: risk of malnutrition; MN: malnourished.
Nutritional status and biomarkers in patients with hip fracture.
| Authors | Design | Anthropometry | (1) Exclusion Criteria | Main Outcomes | |
|---|---|---|---|---|---|
| Mansell | Observational | MAC (cm) | (1) For healthy female: housebound or wheelchairs | Fractured group were older than healthy subjects ( | |
| HF = 77.3 ± 0.3 years | TSF (mm) | ||||
| Maffulli | Observational | (1) Pathologic fracture | Malnourished → 45% IC vs. 20% IT (p < 0.001) | ||
| Murphy | Observational | Albumin 36.9 ± 4.7 g/L | (1) Cognitive impairment | Patients had low mean values for body weight, albumin and transferrin | |
| Lumbers | Cross-sectional | (1) Mental function test < 7 | HF patients vs. day center attendees have: | ||
| Nematy | Observational | Albumin 36 ± 2.6 g/L | (1) Pathological fracture or elective surgery | At risk of malnutrition group ( | |
| Perez | Observational | TSF 5.5 ± 2.3 mm | (1) NA | Length of hospital stay: men 15.3 ± 5.8 days; women 14.9 ± 12 days | |
| Perez | Observational | (1) No osteoporotic fractures or major trauma | HF has lower BMI, arm and leg circumference than community dwelling ( | ||
| Koren-Hakim | Retrospective | WN28.1 ± 4.0 kg/m2 | (1) Terminal illnesses and multi-trauma | MNA ↔ BMI, ADL, cognitive status, readmission, mortality 36 m, CCI and CIRS-G | |
| Villani | Cross-sectional | M: | (1) Pathological fracture or malignancy, residing in residential care | Patients with cachexia: | |
| Bell | Prospective | NA | (1) NA | Malnutrition prevalence with different tools: BMI (12.7%), MNA-SF (27%), ICD10-AM (48.2%), Albumin (53.2%), subjective assessment (55.1%) |
ADL: activities of daily living; AFA: arm fat area; AMA: arm muscle area; ARM: at risk of malnutrition; BMI: body mass index; BSF: biceps skinfold; CIRS-G: cumulative illness rating scale for geriatrics; CRP: C-reactive protein; HF: hip fracture; ICD10-AM: international classification of disease 10th revision-Australian modification; MAC: mid-arm circumference; MN: malnourished; MNA: Mini Nutritional Assessment; MUAMC: mid-upper arm muscle circumference; TSF: triceps skinfold; WN: well-nourished. . ↓: lower; ↓↓ much lower; ↔: correlation.
Association of nutritional status, as revealed by nutritional biomarkers, with outcomes and post-operative complications.
| Authors | Design | BMI (kg/m2) | Exclusion Criteria | Main Outcomes | |
|---|---|---|---|---|---|
| Formiga | Prospective observational | Cholesterol 4.3 ± 1.1 mmol/L | Pathological or multiple fractures, terminally ill patients, surgery delayed | MNA-SF → 11 ± 0.5 | |
| Montero | Prospective cohort | 25(OH)vitD 10.8 ± 5.3 ng/ml | Pathologic or major trauma fractures | 38.8% regained pre-fracture functional state pre-fracture functional status 10.02, 2.83–35.47 Caloric malnutrition 9.57 (2.18–42.84) Protein malnutrition 15.23 (1.36–1.70) | |
| Baumgarten | Prospective cohort | 23.8 ± 5.1 kg/m2 | Fractures occurred during hospital stay | Pressure ulcers at baseline ↔ ↑ severe illness, ↑ comorbidity, ↓ nutritional status, ↓cognitive status ( | |
| Drevet | Prospective observational | 22.6 ± 4.3 kg/m2 | Road accident | Prevalence of PEM was 28% ( | |
| Goisser | Observational | NA | Terminal state, cancer-related pathologic fractures, cancer with acute radiation or chemotherapy | Patients at risk for malnutrition and malnourished: Baseline, ↑ comorbidities ↑ Charlson comorbidity index ↑ pressure ulcers ↓ cognitive status ( All times, ↓ ADL score ( 68% did not regain pre-fracture ADL 18% did not regain pre-fracture mobility level ( | |
| Bohl | Retrospective | 24.6 ± 5.6 kg/m2 | Preoperative serum albumin concentration not available | 18.5% had BMI < 20 kg/m2 of death (RR 1.52. 95%CI 1.37–1.70. of sepsis (RR 1.92. 95%CI 1.36–2.72. of longer legnth of hospital stay, 5.7 ± 4.7 vs. 5.0 ± 3.9 days ( | |
| Helminen | Prospective | 24.9 kg/m2 | Pathological or periprosthetic fractures, institutionalization, prefecture inability to walk | All nutritional measures were significantly associated with mortality | |
| Mazzola | Prospective | NA | Nonoperative approach and preoperative delirium | Risk to develop postoperative delirium: at risk for malnutrition: OR 2.42, 95%CI 1.29–4.53 malnourished: OR 2.98, 95%CI 1.43–6.19 | |
| Inoue | Prospective | 204 (39/165) | 20.2 ± 2.5 kg/m2 | Terminal disease, chronic liver disease, pre-fracture ambulation difficulty, no weight-bearing, discontinued postoperative rehabilitation | Well-nourished had higher motor-FIM score at discharge |
ADL: activities of daily living; BMI: body mass index; FIM: functional Independence Measure; HF: hip fracture; MNA: Mini Nutritional Assessment; PEM: protein energy malnutrition; OR: odd-ratio; 95%CI: 95% confidence interval. ↔: correlation.
Relationship between nutritional status and mortality.
| Authors | BMI kg/m2 (Mean ± SD) | Exclusion Criteria | Main Outcomes | |
|---|---|---|---|---|
| Miyanishi | 21 ± 2.9 (Survivors) | NA | Non-survivors have: | |
| Schaller | NA | Severe cognitive impairment (MMSE > 15) or delirium | Risk factor for ↑mortality (1-year mortality): | |
| Gumieiro | NA | Pathological fracture | MNA ↔ gait impairment OR = 0.77 (0.66–0.90) | |
| Flodin | 22.7 ± 3.8 kg/m2 | Severe cognitive impairment, admitted from nursing-homes | 1-year mortality ( | |
| Uriz-Otano | NA | Tumor, high impact fracture | 3-year mortality: |
MMSE: Mini-Mental State Examinatio; RCT: randomized clinical trial; ↓*: significantly less; ↑*: significantly more.
Total mortality during hospital stay, and at various stages after discharge.
| Reference | In-Hospital | <6 Months | 1 Year | 36 Months | >36 Months | |
|---|---|---|---|---|---|---|
| [ | 6% | 36.7% | 215 | |||
| [ | 6% | 119 | ||||
| [ | 7.4% | 17,651 | ||||
| [ | 27% | 173 | ||||
| [ | 15% | 97 | ||||
| [ | 7.70% | 152 | ||||
| [ | 30% | 26% | 594 | |||
| [ | 4.9% | 14.8% | 142 | |||
| [ | 4% | 21.1% | 171 | |||
| [ | 29.1% | 42.40% | 420 | |||
| [ | 10% | 73 | ||||
| [ | 6.4% | 11.8% | 19.4% | 110 | ||
| [ | 48% | 129 | ||||
| [ | 27% | 857 | ||||
| [ | 12.8% | 86 | ||||
| [ | 1.7% | 17.9% | 57 | |||
| [ | 11.6% | 20.6% | 302 | |||
| Total mortality (%) | 7.4% | 20.4% | 29.3% | 39.4% | 48% | |
Nutritional intervention in patients with hip fracture.
| Author | Design | BMI kg/m2 (Mean ± SD) | Exclusion Criteria | Results | |
|---|---|---|---|---|---|
| Schürch [ | RCT | 24.3 ± 4.0 kg/m2 | Pathologic fracture, fracture caused by severe trauma, history of contralateral hip fracture, severe mental impairment, bone disease, renal failure, and life expectancy < 1 year | IG (at 6m): | |
| Espaulella [ | RCT | 25.4 ± 5 kg/m2 | Advanced dementia, intravenous nutrition, pathologic fractures, and accidental falls | Patients with ≥1 complication (6 months): | |
| Bruce [ | RCT | 22.8 ± 2.6 kg/m2 | BMI < 20 or BMI > 30 kg/m2, residents of nursing homes, diseases that influence nutritional intake, diabetes, and fracture due to a major trauma | Weight loss (all patients): | |
| Houwing [ | RCT | 23.9 ± 0.5 kg/m2 | Terminal care, metastatic hip fracture, insulin-dependent diabetes, renal disease, hepatic disease, BMI > 40 kg/m2. | 55.3% developed pressure ulcers stage I or II. | |
| Sullivan [ | RCT | 22.1 ± 4.4 kg/m2 | Pathological fracture, significant trauma to other organ systems, metastatic cancer, cirrhosis of the liver, and organ failure | IG: | |
| Tidermark [ | RCT | 20.4 ± 2.3 kg/m2 | <70 years, BMI > 24 kg/m2, cognitive impairment and institutionalized, dependent to walk, fractures older than 24 h, pathological fractures, rheumatoid arthritis. | Lean body mass decreased in the CG and protein groups, but remained the same in the protein plus nandrolone group. | |
| Eneroth [ | RCT | 23.9 ± 3.8 kg/m2 | Multiple and pathologic fractures, malignant disease, inflammatory joint disease, dementia, depression, acute psychosis, epileptic seizures, insulin-treated diabetes mellitus, heart, kidney, or liver insufficiency | PEM baseline: | |
| Duncan [ | RCT | NA | Pathologic fracture | Mortality Energy intake = IG 1105; CG 756 kcal/day ( Supplement intake: IG 409; CG123 kcal/day ( MAC change: IG −0.9; CG −1.3 cm ( | |
| Hommel [ | Quasi-experimental | 24.3 ± 4.4 kg/m2 | NA | Length of hospital stay: IG 11.8 ± 7.4 vs. CG 10.8 ± 5.8 days | |
| Botella-Carretero [ | RCT | 24.4 ± 3.1 kg/m2 | Weight loss > 5% in 1 month or weight loss > 10% in 6 months, albumin < 27 g/L, renal failure, hepatic insufficiency, respiratory failure, and any gastrointestinal condition, any nutritional support in the past 6 months | CG: decrease and worse recovery of albumin and prealbumin ( | |
| Fabian [ | RCT | 21.2 ± 3.4 kg/m2 | Renal disease, liver failure, severe congestive heart failure, severe pulmonary disease, and any gastrointestinal condition that might preclude the patient from adequate oral nutritional intake | IG ↑ energy and protein intake ( | |
| Hoekstra [ | Prospective | 26.8 ± 4.5 kg/m2 | Severe dementia, cancer, pathologic fracture, renal and hepatic dysfunction, pacemaker | IG ↑ energy intake protein, vitamin D, zinc, calcium ( | |
| Li [ | Randomized (1 year) | NA | Cognitive impairment, terminally ill | Malnutrition prevalence: IG 60% vs. CG 67% | |
| Wyers [ | RCT | NA | Pathological or periprosthetic fracture, disease of bone metabolism, life expectancy < 1 year, ONS before hospital admission, dementia. | The additional cost of the nutritional intervention was only 3% of the total cost | |
| Myint [ | RCT | 20.7 ± 2.9 kg/m2 | Tube feeding, unstable medical condition, BMI ≥ 25 kg/m2, malignancy, contraindication for high-protein diet, and mentally incapacitated | BMI decrease of 0.25 and 0.003 kg/m2 in the ONS group, and 0.72 and 0.49 kg/m2 at hospital and follow-up ( | |
| Anbar [ | RCT | 24.9 ± 3.9 kg/m2 | Presented to hospital >48 h after the injury, steroids and/or immunosuppression therapy, oncologic disease, multiple fractures, dementia | ONS = 19.6% of total energy | |
| Ekinci [ | RCT | 22.0 ± 2.4 kg/m2 | Diabetes, renal and hepatic failure, gastrointestinal intolerance, endocrine pathology, and dementia. | Patients who were mobile on day 30: | |
| Malafarina [ | RCT | 25.4 ± 4.9 kg/m2 | Diabetes, Barthel index <40 prior to the fracture, tumor, pathological or high-impact fractures | BMI and ALM was stable in IG, but decreased in CG. |
ALM = appendicular lean mass; AOPP: advanced oxidation protein products; BCM: Body Cellular Mass; BMI = body mass index; BSF = biceps skinfold thickness; CG = control group; FM: fatt mass; IADL: instrumental activities o daily living; IGF-1 = insulin-like growth factor; HS = handgrip strength; IG = intervention group; MAC = mid-arm circumference; MNA = Mini Nutritional Assessment; ONS = oral nutritional supplement; RCT = randomized controlled trial; TSF = triceps skin fold thickness; ↓* = significantly less; ↑* = significantly more; ↔ = significant association.
Characteristics of the nutritional intervention and composition of the nutritional supplementation used in the included studies.
| Author | Type of Supplement | kcal | Nutritional Composition | Treatment Duration | Control Group |
|---|---|---|---|---|---|
| Schürch [ | Oral liquid supplement; single oral dose of vit D3 200.000 UI | 250 kcal/day | 20 g protein, 3.1 g lipid, 35.7 g carbohydrates, | 5 days a week for 6 months | Placebo: 54.5 g carbohydrates |
| Espaulella [ | Oral liquid supplement | 149 kcal | 20 g protein, 800 mg calcium, 25 IU vitamin D3 | 60 days | Placebo 200 mL, 155 kcal; mainly carbohydrates |
| Bruce [ | Oral liquid supplement (235 mL/day) | 352 kcal | 17.6 g protein, 11.8 g fat, 44.2 g carbohydrate, vitamins and minerals | 28 days after surgery | Hospital diet only |
| Houwing [ | Oral liquid supplement (400 mL/day) | 500 kcal | 40 g protein | Immediately postoperatively during 4 weeks or until discharge | Non-caloric placebo supplement |
| Sullivan [ | Standard care + post-operative nightly via enteral feeding tube: | 1031 kcal | 85.8 g protein | When volitional intake exceeded 90% of estimated requirements for 3 consecutive days or was discharged: mean 15.8 ± 16.4 days | Standard care |
| Tidermark [ | PR: protein-rich liquid supplement (200 mL/day) | 200 kcal/day | 20 g protein | 6 months | Standard treatment |
| Eneroth [ | Hospital diet + intravenous nutrition (1 l/day) followed by | Oral supplement 400 kcal/day | IV: amino acids, fat, carbohydrate, and electrolytes | 3 days → IV | Hospital diet only |
| Duncan [ | NA | Mean supplement: 409 kcal/day | NA | NA | Mean standard supplement: 123 kcal/day |
| Hommel [ | Oral nutritional supplement twice a day | 125 kcal/100 mL enriched with arginine, zinc, vitamins A, B, C, and E, selenium, and carotenoids | NA | From post-surgery to discharge | NA |
| Botella-Carretero [ | Oral nutritional supplement intake (2 × 200 mL/day) | 400 kcal/day | 40 g protein/day | From admission until discharge | Control group: no supplement |
| Fabian [ | Oral liquid supplement | Supplements were administered when intake of energy < 20 kcal and/or protein < 1 g/kg body weight/day | 40% protein, 41% carbohydrate, 19% fat, vitamins and minerals | From post-surgery to discharge | Standard medical treatment |
| Hoekstra [ | Nurse and doctor encouraged and motivated patients to eat and drink; if MNA < 24, dietician consulted with the patient | NA | NA | NA | Standard nutritional care |
| Wyers [ | Oral liquid nutritional supplement (500 mL/day) | 500 kcal | 40 g protein | Started during hospital admission and continued until 3 months after surgery | Usual care |
| Myint [ | Oral liquid nutritional supplement (240 mL twice daily) | 500 kcal | 18–24 g protein | Started within 3 days after admission until discharge or 28 days | NA |
| Anbar [ | Standard ONS (237 mL) or | 355 kcal | 13.5 g protein | Started 24 h after surgery | Usual hospital diet = 1800 kcal, 80 g protein |
| Ekinci [ | Oral liquid nutritional supplement (220 mL twice daily) | NA | 36 g protein | 30 days | Usual hospital diet: 1900 kcal, 76 g protein, 63 g fat |
| Malafarina [ | Oral liquid nutritional supplement (220 mL twice daily) | 660 kcal | 60 g protein | During hospital admission, until discharge | Usual hospital diet: 1500 kcal, 87 g protein, 59 g fat |